Sign in / Join Now
ETFs & Funds
Arca Biopharma: A Genetically Targeted Drug For Atrial Fibrillation In Heart Failure Patients $
Add a reply...
Latest StockTalks »
people get ABIO breaking news and analysis by email alert.
Get email alerts on ABIO »
ARCA biopharma, Inc.
Get latest price
From other sites
ARCA Biopharma Announces 100th Patient Randomized Into The GENETIC-AF Phase 2B/3 Clinical Trial
at TheStreet (Aug 18, 2016)
ARCA Biopharma Announces Second Quarter 2016 Financial Results And Provides Business Update
at TheStreet (Aug 9, 2016)
Arca Biopharma : Gencaro™ Potential Efficacy Preventing Atrial Flutter in Heart Failure Paper to Be Presented at 2015 HFSA Annual Scientific Meeting
at 4-traders.com (Sep 18, 2015)
Arca Biopharma Inc : ARCA biopharma (ABIO): Leveraging Genetic Targeting to Better Treat Cardiovascular Disease
at 4-traders.com (Sep 15, 2015)
ARCA BIOPHARMA : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
at 4-traders.com (Jul 16, 2015)